Literature DB >> 12477567

Relationships among body mass, its components, and bone.

I R Reid1.   

Abstract

Body weight impacts on both bone turnover and bone density, and is therefore an important risk factor for vertebral and hip fractures, ranking in importance alongside that of age. The effect of body weight is probably contributed to by both fat mass and lean mass, although in postmenopausal women fat mass has been more consistently demonstrated to be important. A number of mechanisms for the fat-bone relationship exist and include the effect of soft tissue mass on skeletal loading, the association of fat mass with the secretion of bone-active hormones from the pancreatic beta cell (including insulin, amylin, and preptin), and the secretion of bone-active hormones (e.g., estrogens and leptin) from the adipocyte. These factors alone probably do not fully explain the observed clinical associations, and further study of the actions on bone of novel hormones related to nutrition is an important area of further research. An understanding of this aspect of bone biology may open the way for new treatments of osteoporosis. More immediately, the role of weight maintenance in the prevention of osteoporosis is an important public health message that needs to be more widely appreciated.

Entities:  

Mesh:

Year:  2002        PMID: 12477567     DOI: 10.1016/s8756-3282(02)00864-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  184 in total

1.  Low urine pH and acid excretion do not predict bone fractures or the loss of bone mineral density: a prospective cohort study.

Authors:  Tanis R Fenton; Misha Eliasziw; Suzanne C Tough; Andrew W Lyon; Jacques P Brown; David A Hanley
Journal:  BMC Musculoskelet Disord       Date:  2010-05-10       Impact factor: 2.362

2.  Obesity alters cortical and trabecular bone density and geometry in women.

Authors:  D Sukumar; Y Schlussel; C S Riedt; C Gordon; T Stahl; S A Shapses
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

3.  Body mass index and bone loss among postmenopausal women: the 10-year follow-up of the OSTPRE cohort.

Authors:  Jarmo Saarelainen; Vesa Kiviniemi; Heikki Kröger; Marjo Tuppurainen; Leo Niskanen; Jukka Jurvelin; Risto Honkanen
Journal:  J Bone Miner Metab       Date:  2011-09-22       Impact factor: 2.626

4.  Soy milk and dairy consumption is independently associated with ultrasound attenuation of the heel bone among postmenopausal women: the Adventist Health Study-2.

Authors:  Vichuda Lousuebsakul Matthews; Synnove F Knutsen; W Lawrence Beeson; Gary E Fraser
Journal:  Nutr Res       Date:  2011-10       Impact factor: 3.315

5.  Relationship between body composition and bone mineral density in healthy young and premenopausal Chinese women.

Authors:  Jian-Min Liu; Hong-Yan Zhao; Guang Ning; Yong-Ju Zhao; Lian-Zhen Zhang; Li-Hao Sun; Man-Yin Xu; Jia-Lun Chen
Journal:  Osteoporos Int       Date:  2004-01-16       Impact factor: 4.507

6.  Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women.

Authors:  Kathleen E Bainbridge; MaryFran Sowers; Xihong Lin; Sioban D Harlow
Journal:  Osteoporos Int       Date:  2004-01-22       Impact factor: 4.507

7.  Bone mineral mass in males and females with and without Down syndrome.

Authors:  Fatima Baptista; Ana Varela; Luis B Sardinha
Journal:  Osteoporos Int       Date:  2004-09-09       Impact factor: 4.507

8.  The relationship between body composition and bone mineral density in postmenopausal Turkish women.

Authors:  Hakan Nur; N Fusun Toraman; Zuhal Arica; Nur Sarier; Anil Samur
Journal:  Rheumatol Int       Date:  2012-04-06       Impact factor: 2.631

9.  Bone and fat relationships in postadolescent black females: a pQCT study.

Authors:  N K Pollock; E M Laing; M W Hamrick; C A Baile; D B Hall; R D Lewis
Journal:  Osteoporos Int       Date:  2010-05-07       Impact factor: 4.507

Review 10.  The obesity of bone.

Authors:  Emanuela A Greco; Andrea Lenzi; Silvia Migliaccio
Journal:  Ther Adv Endocrinol Metab       Date:  2015-12       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.